Siemens Fonds Invest GmbH Has $17.94 Million Position in McKesson Co. (NYSE:MCK)

Siemens Fonds Invest GmbH boosted its position in McKesson Co. (NYSE:MCK) by 623.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,470 shares of the company’s stock after buying an additional 27,119 shares during the quarter. McKesson makes up about 0.9% of Siemens Fonds Invest GmbH’s portfolio, making the stock its 20th biggest position. Siemens Fonds Invest GmbH’s holdings in McKesson were worth $17,935,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Frank Rimerman Advisors LLC increased its stake in McKesson by 2.2% in the 4th quarter. Frank Rimerman Advisors LLC now owns 807 shares of the company’s stock valued at $460,000 after buying an additional 17 shares during the last quarter. Trust Co. of Vermont boosted its position in McKesson by 4.8% during the fourth quarter. Trust Co. of Vermont now owns 393 shares of the company’s stock valued at $224,000 after purchasing an additional 18 shares during the last quarter. Hemington Wealth Management grew its stake in McKesson by 18.6% in the fourth quarter. Hemington Wealth Management now owns 115 shares of the company’s stock valued at $65,000 after purchasing an additional 18 shares in the last quarter. First Western Trust Bank raised its stake in shares of McKesson by 2.0% during the 4th quarter. First Western Trust Bank now owns 931 shares of the company’s stock worth $531,000 after purchasing an additional 18 shares in the last quarter. Finally, Calamos Wealth Management LLC grew its stake in shares of McKesson by 0.4% in the fourth quarter. Calamos Wealth Management LLC now owns 4,677 shares of the company’s stock valued at $2,665,000 after buying an additional 20 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on MCK shares. Bank of America boosted their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. StockNews.com upgraded McKesson from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Cfra Research downgraded McKesson from a “moderate buy” rating to a “hold” rating in a report on Friday, April 4th. UBS Group lifted their price objective on shares of McKesson from $708.00 to $805.00 and gave the stock a “buy” rating in a research report on Tuesday, April 29th. Finally, Evercore ISI raised their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research note on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and a consensus price target of $686.69.

McKesson Price Performance

Shares of NYSE:MCK opened at $705.78 on Friday. The company has a market capitalization of $88.45 billion, a P/E ratio of 32.32, a P/E/G ratio of 1.29 and a beta of 0.53. The business’s 50 day simple moving average is $681.75 and its 200 day simple moving average is $625.19. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $728.48.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, beating analysts’ consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. McKesson’s revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.18 earnings per share. On average, sell-side analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. The ex-dividend date is Monday, June 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.40%. McKesson’s dividend payout ratio is currently 10.99%.

Insider Activity at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This represents a 12.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.11% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.